- Home
- AXS vs TECH Comparison
AXS vs TECH Comparison
Compare AXS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXS
- TECH
- Stock Information
- Founded
- AXS 2001
- TECH 1976
- Country
- AXS Bermuda
- TECH United States
- Employees
- AXS N/A
- TECH N/A
- Industry
- AXS Property-Casualty Insurers
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXS Finance
- TECH Health Care
- Exchange
- AXS Nasdaq
- TECH Nasdaq
- Market Cap
- AXS 8.1B
- TECH 7.8B
- IPO Year
- AXS N/A
- TECH 1989
- Fundamental
- Price
- AXS $102.54
- TECH $49.15
- Analyst Decision
- AXS Strong Buy
- TECH Buy
- Analyst Count
- AXS 9
- TECH 10
- Target Price
- AXS $107.75
- TECH $73.44
- AVG Volume (30 Days)
- AXS 565.6K
- TECH 2.3M
- Earning Date
- AXS 04-30-2025
- TECH 05-07-2025
- Dividend Yield
- AXS 1.72%
- TECH 0.65%
- EPS Growth
- AXS 54.31
- TECH N/A
- EPS
- AXS 10.08
- TECH 0.83
- Revenue
- AXS $6,055,200,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- AXS $4.15
- TECH $8.19
- Revenue Next Year
- AXS $5.74
- TECH $8.61
- P/E Ratio
- AXS $10.14
- TECH $59.07
- Revenue Growth
- AXS 5.79
- TECH 4.72
- 52 Week Low
- AXS $68.02
- TECH $46.44
- 52 Week High
- AXS $101.42
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- AXS 64.39
- TECH 44.74
- Support Level
- AXS $98.40
- TECH $46.35
- Resistance Level
- AXS $102.36
- TECH $54.40
- Average True Range (ATR)
- AXS 2.23
- TECH 2.17
- MACD
- AXS 0.26
- TECH 0.27
- Stochastic Oscillator
- AXS 99.79
- TECH 34.78
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.